Methylene blue reduces acute cerebral ischemic injury via the induction of mitophagy

Molecular Medicine

Volumn 21, Issue , 2015, Pages 420-429

  Di, Yao ^a   He, Yun Ling ^a   Zhao, Tong ^a   Huang, Xin ^a   Wu, Kui Wu ^a   Liu, Shu Hong ^a   Zhao, Yong Qi ^a   Fan, Ming ^a,b,c   Wu, Li Ying ^a   Zhu, Ling Ling ^a,b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b NANTONG UNIVERSITY   (China)

^c BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; GLUCOSE; METHYLENE BLUE; OXYGEN; REACTIVE OXYGEN METABOLITE; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGOSOME; BLOOD BRAIN BARRIER; BODY POSTURE; BRAIN CELL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME ACTIVITY; GRID TEST; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOPHAGY; NEUROPROTECTION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CEREBRAL ARTERY DISEASE; DISEASE MODEL; DRUG EFFECTS; HUMAN; METABOLISM; NECROSIS; PATHOLOGY; STROKE;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GLUCOSE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; METHYLENE BLUE; MITOCHONDRIAL DEGRADATION; NECROSIS; NEUROPROTECTIVE AGENTS; OXYGEN; RATS; REPERFUSION INJURY; STROKE;

EID: 84940395578     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00038     Document Type: Article

References (53)

1. Wainwright M, Crossley KB. (2002) Methylene Blue - a therapeutic dye for all seasons? J. Chemother. 14:431-43.
2. Tretter L, Horvath G, Holgyesi A, Essek F, Adam- Vizi V. (2014) Enhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria. Free Radic. Biol. Med. 77:317-30.
3. Oz M, Lorke DE, Hasan M, Petroianu GA. (2011) Cellular and molecular actions of Methylene Blue in the nervous system. Med. Res. Rev. 31:93-117.
4. Callaway NL, Riha PD, Bruchey AK, Munshi Z, Gonzalez-Lima F. (2004) Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol. Biochem. Behav. 77:175-81.
5. Zhang X, Rojas JC, Gonzalez-Lima F. (2006) Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox. Res. 9:47-57.
6. Riha PD, Bruchey AK, Echevarria DJ, Gonzalez- Lima F. (2005) Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur. J. Pharmacol. 511:151-8.
7. Rojas JC, Bruchey AK, Gonzalez-Lima F. (2012) Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog. Neurobiol. 96:32-45.
8. Kelner MJ, Bagnell R, Hale B, Alexander NM. (1988) Potential of methylene blue to block oxygen radical generation in reperfusion injury. Basic Life Sci. 49:895-8.
9. Cawein M, Behlen CH 2nd, Lappat EJ, Cohn JE. (1964) Hereditary diaphorase deficiency and methemoglobinemia. Arch Intern Med 113:578-85.
10. Draize JH. (1933) Sodium tetrathionate and methylene blue in cyanide and carbon monoxide poisoning. Science. 78:145.
11. Wen Y, et al. (2011) Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J. Biol. Chem. 286:16504-15.
12. Miclescu A, Sharma HS, Martijn C, Wiklund L. (2010) Methylene blue protects the cortical bloodbrain barrier against ischemia/reperfusion-induced disruptions. Crit. Care Med. 38:2199-206.
13. Shen Q, et al. (2013) Neuroprotective efficacy of methylene blue in ischemic stroke: an MRI study. PLoS One. 8:e79833.
14. Gropen TI, et al. (2006) Quality improvement in acute stroke: the New York State Stroke Center Designation Project. Neurology. 67:88-93.
15. Ertracht O, Malka A, Atar S, Binah O. (2014) The mitochondria as a target for cardioprotection in acute myocardial ischemia. Pharmacol. Ther. 142:33-40.
16. Kim SY, et al. (2014) Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury. Cell Death Dis. 5:e1105.
17. Ikeda Y, et al. (2015) Endogenous drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ. Res. 116:264-78.
18. Lemasters JJ. (2005) Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 8:3-5.
19. Youle RJ, Narendra DP. (2011) Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12:9-14.
20. Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL. (2014) Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell Biol. 206:655-70.
21. Liu L, et al. (2012) Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14:177-85.
22. Kim I, Lemasters JJ. (2011) Mitophagy selectively degrades individual damaged mitochondria after photoirradiation. Antioxid. Redox. Signal. 14:1919-28.
23. Wu H, et al. (2014) The BCL2L1 and PGAM5 axis defines hypoxia-induced receptor-mediated mitophagy. Autophagy. 10:1712-25.
24. Kurihara Y, et al. (2012) Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J. Biol. Chem. 287:3265-72.
25. Bin-Umer MA, McLaughlin JE, Butterly MS, Mc- Cormick S, Tumer NE. (2014) Elimination of damaged mitochondria through mitophagy reduces mitochondrial oxidative stress and increases tolerance to trichothecenes. Proc. Natl. Acad. Sci. U. S. A. 111:11798-803.
26. Schapira AH, Olanow CW, Greenamyre JT, Bezard E. (2014) Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet 384:545-55.
27. Shiba-Fukushima K, et al. (2014) Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes parkin mitochondrial tethering. PLoS. Genet. 10:e1004861.
28. Santos RX, et al. (2011) Mitophagy in neurodegeneration: an opportunity for therapy? Curr. Drug Targets. 12:790-9.
29. Rubinsztein DC, Marino G, Kroemer G. (2011) Autophagy and aging. Cell. 146:682-95.
30. Martinez-Vicente M, et al. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 13:567-76.
31. Lemasters JJ, et al. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta. 1366:177-96.
32. Hollville E, Carroll RG, Cullen SP, Martin SJ. (2014) Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin/PINK1-dependent mitophagy. Mol. Cell. 55:451-66.
33. Strappazzon F, et al. (2015) AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 22:419-32.
34. Zhang JH, et al. (2015) 5-HMF prevents against oxidative injury via APE/Ref-1. Free Radic. Res. 49:86-94.
35. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. (1996) Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke. 27:1616-22; discussion 1623.
36. Baskin YK, Dietrich WD, Green EJ. (2003) Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice. J. Neurosci. Methods. 129:87-93.
37. Lin TN, He YY, Wu G, Khan M, Hsu CY. (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-21.
38. Liu H, et al. (2015) Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer. Cell Death Dis. 6:e1595.
39. Back SA, et al. (2007) Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J. Cereb. Blood Flow Metab. 27:334-47.
40. Flameng W, Borgers M, Daenen W, Stalpaert G. (1980) Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J. Thorac. Cardiovasc. Surg. 79:413-24.
41. Li Y, et al. (2011) Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication. Toxicol. Appl. Pharmacol. 253:261-9.
42. Cheng X, et al. (2014) A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1- p38-MAPK signaling in pancreatic cancer cells. Mol. Cancer. 13:221.
43. Moskowitz MA, Lo EH, Iadecola C. (2010) The science of stroke: mechanisms in search of treatments. Neuron. 67:181-98.
44. Narayan N, et al. (2012) The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature. 492:199-204.
45. Wang Z, Jiang H, Chen S, Du F, Wang X. (2012) The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell. 148:228-43.
46. Singhal A, Morris VB, Labhasetwar V, Ghorpade A. (2013) Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 4:e903.
47. Poteet E, et al. (2012) Neuroprotective actions of methylene blue and its derivatives. PLoS One. 7:e48279.
48. Lopez-Valdes HE, et al. (2014) Memantine enhances recovery from stroke. Stroke. 45:2093-100.
49. Coulibaly B, et al. (2015) Efficacy and safety of triple combination therapy with artesunateamodiaquine- methylene blue for falciparum malaria in children: a randomized controlled trial in burkina faso. J. Infect. Dis. 211:689-697.
50. Congdon EE, et al. (2012) Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy. 8:609-22.
51. Kubli DA, Gustafsson AB. (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ. Res. 111:1208-21.
52. Bagkos G, Koufopoulos K, Piperi C. (2014) A new model for mitochondrial membrane potential production and storage. Med. Hypotheses. 83:175-81.
53. Gabrielli D, Belisle E, Severino D, Kowaltowski AJ, Baptista MS. (2004) Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochem. Photobiol. 79:227-32.